General Surgery

Uzm. Dr. Merve Tokoçin

Doctor and researcher Bağcılar Eğitim ve Araştırma Hastanesi İstanbul
Breast NeoplasmsAppendicitisCOVID-19Pilonidal SinusSurgical Wound InfectionPeptic Ulcer PerforationLymphedemaPostoperative Pain
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Appendicitis 3 publications
  • COVID-19 3 publications
  • Pilonidal Sinus 2 publications
  • Surgical Wound Infection 2 publications
  • Peptic Ulcer Perforation 2 publications
  • Lymphedema 2 publications
  • Postoperative Pain 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyGeneral Surgerysaglik.gov.trFrom source
  • InstitutionBağcılar Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 7 publications · Model version —From source
  • Publications78 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0001-8040-300XORCIDFrom source
  • Last synchronised5 November 2026 08:55https://bagcilareah.saglik.gov.tr/TR-1478343/doktorlarimiz.html#merve-tokocinsaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

78 publications

  1. Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15051898 PMID 41827314 Open-access full textSource: OpenAlex

  2. Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy

    Medicina, 2026

    DOI 10.3390/medicina62010200 PMID 41597486 Open-access full textSource: OpenAlex

  3. Association of Post-Neoadjuvant Chemotherapy MRI and 18F-FDG PET/CT Findings with Tumor Response and Prognosis in Breast Cancer

    Diagnostics, 2026

    DOI 10.3390/diagnostics16050713 PMID 41827989 Open-access full textSource: OpenAlex

  4. Pathological Response and Survival Outcomes Following Neoadjuvant Chemotherapy in HR+/HER2- Breast Cancer: Real-world Experience

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-3-9 Open-access full textSource: OpenAlex

  5. Radiotracer-Free Axillary Staging with ICG and Methylene Blue After Neoadjuvant Chemotherapy: Does Failure to Retrieve the Clipped Node Matter?

    Cancers, 2026

    DOI 10.3390/cancers18162550 PMID 42649865 Open-access full textSource: OpenAlex

  6. Abstract PS4-08-08: Comparison of localization techniques for non-palpable breast cancer: real world data

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps4-08-08 Source: OpenAlex

  7. Surgical preference and outcomes in pilonidal sinus disease: a national multicenter study evaluating complications, recurrence, and quality of life (PISI TURKEY)

    Techniques in Coloproctology, 2026

    DOI 10.1007/s10151-026-03290-z PMID 41838186 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  8. Predictors of the major and minor ileostomy complications following ileostomy closure in rectal cancer patients: a retrospective cohort study

    Journal of Trends in Medical Investigation, 2026

    DOI 10.64512/jtmi.2026.25 Open-access full textSource: ORCID

  9. Thirty-Day Mortality and Morbidity Outcomes in Abdominal Wall Necrotizing Soft Tissue Infections: The STANMORE Study

    World journal of surgery, 2026

    DOI 10.1002/wjs.70558 PMID 42723299 Open-access full textSource: Europe PMC

  10. Carvacrol Selectively Induces Mitochondria-Related Apoptotic Signaling in Primary Breast Cancer-Associated Fibroblasts

    Pharmaceuticals, 2026

    DOI 10.3390/ph19010142 PMID 41599740 1 citation (Europe PMC) Open-access full textSource: ORCID

View all 78 publications